Development of resistance to acyclovir during chronic infection with the oka vaccine strain of varicella-zoster virus, in an immunosuppressed child

被引:68
作者
Levin, MJ
Dahl, KM
Weinberg, A
Giller, R
Patel, A
Krause, PR
机构
[1] Univ Colorado, Hlth Sci Ctr, Sect Pediat Infect Dis, Denver, CO 80262 USA
[2] Univ Colorado, Hlth Sci Ctr, Sect Pediat Hematol Oncol & Bone Marrow Transplan, Denver, CO 80262 USA
[3] US FDA, Ctr Biol Evaluat & Res, Bethesda, MD USA
关键词
D O I
10.1086/378502
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A 1-year-old boy was vaccinated with the Oka strain of varicella just prior to the discovery of a tumor that required intensive antitumor therapy. Three months later he developed herpes zoster, which developed into chronic verrucous lesions that were refractory to treatment with acyclovir and which subsequently disseminated. DNA from a biopsy specimen of a chronic herpes-zoster lesion indicated that the Oka vaccine strain of the the virus caused this severe complication. Analysis of this viral DNA demonstrated a mutation in the viral thymidine kinase gene. Plasmids containing this altered gene were unable to produce functional thymidine kinase in an in vitro translation system. The presence of this mutation would explain the clinical resistance to acyclovir. This is the first report of Oka-strain varicella virus causing severe disease after reactivation and of resistance to acyclovir during an infection caused by this virus.
引用
收藏
页码:954 / 959
页数:6
相关论文
共 37 条
[21]  
LEBOIT PE, 1992, AM J DERMATOPATH, V14, P1
[22]  
LEIBOVITZ E, 1992, CUTIS, V49, P27
[23]   Improved identification and differentiation of varicella-zoster virus (VZV) wild-type strains and an attenuated varicella vaccine strain using a VZV open reading frame 62-based PCR [J].
Loparev, VN ;
Argaw, T ;
Krause, PR ;
Takayama, M ;
Schmid, DS .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (09) :3156-3160
[24]   Phenotypic and genetic characterization of thymidine kinase from clinical strains of Varicella-Zoster virus resistant to acyclovir [J].
Morfin, F ;
Thouvenot, D ;
de Turenne-Tessier, M ;
Lina, B ;
Aymard, M ;
Ooka, T .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (10) :2412-2416
[25]   VARICELLA IN IMMUNOCOMPROMISED CHILDREN [J].
MORGAN, ER ;
SMALLEY, LA .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1983, 137 (09) :883-885
[26]  
Nikkels AF, 1999, CLIN EXP DERMATOL, V24, P346
[27]  
PAWHA S, 1988, JAMA-J AM MED ASSOC, V260, P2879
[28]   VARICELLA IN PATIENTS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS [J].
PERRONNE, C ;
LAZANAS, M ;
LEPORT, C ;
SIMON, F ;
SALMON, D ;
DALLOT, A ;
VILDE, JL .
ARCHIVES OF DERMATOLOGY, 1990, 126 (08) :1033-1036
[29]   Clinical and virologic characterization of acyclovir-resistant varicella-zoster viruses isolated from 11 patients with acquired immunodeficiency syndrome [J].
Saint-Léger, E ;
Caumes, E ;
Breton, G ;
Douard, D ;
Saiag, P ;
Huraux, JM ;
Bricaire, F ;
Agut, H ;
Fillet, AM .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (12) :2061-2067
[30]   MOLECULAR ANALYSIS OF THE PYRIMIDINE DEOXYRIBONUCLEOSIDE KINASE GENE OF WILD-TYPE AND ACYCLOVIR-RESISTANT STRAINS OF VARICELLA-ZOSTER VIRUS [J].
SAWYER, MH ;
INCHAUSPE, G ;
BIRON, KK ;
WATERS, DJ ;
STRAUS, SE ;
OSTROVE, JM .
JOURNAL OF GENERAL VIROLOGY, 1988, 69 :2585-2593